Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2649
Source ID: NCT00036192
Associated Drug: Fk614
Title: Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus
Interventions: DRUG: FK614
Outcome Measures:
Sponsor/Collaborators: Sponsor: Astellas Pharma Inc | Collaborators: Astellas Pharma US, Inc.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 200
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2002-02
Completion Date: 2006-03
Results First Posted:
Last Update Posted: 2011-12-09
Locations: International Institute of Clinical Research, Inc., Ozark, Alabama, 36360, United States|Arizona Research Associates, Tucson, Arizona, 85712, United States|OCCR @ East Gate Medical Center, Cypress, California, 90630, United States|Clinical Trials of St. Jude Heritage Md Grp, Fullerton, California, 92835, United States|Research Foundation of America, Los Angeles, California, 90035, United States|Progressive Clinical Research, Vista, California, 92083, United States|Diablo Clinical Research, Inc., Walnut Creek, California, 94598, United States|Center for Diabetes and Endocrine Care, Hollywood, Florida, 33021, United States|Physician's Office, Miami, Florida, 33136, United States|University of Miami, Diabetes Center, Miami, Florida, 33136, United States|Baptist Diabetes Associates, Miami, Florida, 33176, United States|Central Florida Clinical Studies, Ocoee, Florida, 34761, United States|Clireco, Inc., Tamarac, Florida, 33321, United States|The Emory Clinic, Atlanta, Georgia, 30322, United States|East-West Medical Institute, Honolulu, Hawaii, 96813, United States|McConnehey Family Medicine, Nampa, Idaho, 83651, United States|Physician's Office, Peoria, Illinois, 61614, United States|Clinical Research, Inc., Waltham, Massachusetts, 02453, United States|Radiant Research - Minneapolis, Edina, Minnesota, 55435, United States|Physician's East, Greenville, North Carolina, 27834, United States|Cleveland Clinic, Cleveland, Ohio, 44195, United States|Radiant Research, Mogadorf, Ohio, 44260, United States|Physician's Office, Portland, Oregon, 97232, United States|Physicians for Clinical Research, Camp Hill, Pennsylvania, 17011, United States|Fleetwood Medical Associates, Fleetwood, Pennsylvania, 19522, United States|Founders Research Corp., Philadelphia, Pennsylvania, 19124, United States|SFM Clinical Trials, Scotland, Pennsylvania, 17254, United States|Heartland Medical PC, New Tazewell, Tennessee, 37825, United States|University of Texas Southwestern Medical Center, Dallas, Texas, 75390, United States|Baylor College of Medicine, Houston, Texas, 77030, United States|Mercury Research, Inc., Houston, Texas, 77081, United States|Diabetes / Glandular Disease Research Associates, San Antonio, Texas, 78229, United States|Sam Clinical Research Center, San Antonio, Texas, 78229, United States|McGuire Research Institute, Richmond, Virginia, 23249, United States|Physician's Office, Spokane, Washington, 99216, United States|University Physicians Internal Medicine, Huntington, West Virginia, 25701, United States
URL: https://clinicaltrials.gov/show/NCT00036192

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress